Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company (GCAN) Payables (2016 - 2026)

Greater Cannabis Company has reported Payables over the past 7 years, most recently at $259688.0 for Q4 2022.

  • For Q4 2022, Payables fell 31.8% year-over-year to $259688.0; the TTM value through Dec 2022 reached $259688.0, down 31.8%, while the annual FY2022 figure was $259688.0, 31.8% down from the prior year.
  • Payables for Q4 2022 was $259688.0 at Greater Cannabis Company, up from $149297.0 in the prior quarter.
  • Over five years, Payables peaked at $480392.0 in Q1 2022 and troughed at $9700.0 in Q2 2019.
  • A 5-year average of $169267.2 and a median of $141066.0 in 2018 define the central range for Payables.
  • Biggest five-year swings in Payables: tumbled 93.81% in 2019 and later surged 3178.48% in 2020.
  • Year by year, Payables stood at $17890.0 in 2018, then skyrocketed by 2229.99% to $416835.0 in 2019, then dropped by 20.36% to $331955.0 in 2020, then increased by 14.71% to $380800.0 in 2021, then tumbled by 31.8% to $259688.0 in 2022.
  • Business Quant data shows Payables for GCAN at $259688.0 in Q4 2022, $149297.0 in Q3 2022, and $33346.0 in Q2 2022.